Sponsor Pipeline

Michael Spinner, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07021989
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma		 date change Primary completion pushed: 2029-05-31 -> 2029-07-31
2026-08-13 NCT07021989
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma		 date change Completion pushed: 2033-12-31 -> 2034-03-31
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07021989 ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma Hodgkin Lymphoma, Adult Not Yet Recruiting
Disease Areas
Hodgkin Lymphoma (1)
Get alerts when Michael Spinner, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free